| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc. (EXEL) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. EXEL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.96M | $100.87M | - | |
| Dir | 1.55M | $79.74M | - | |
| Dir | 1.19M | $61.05M | - | |
| CFO | 1.12M | $57.36M | - | |
| VP | 594.7K | $30.53M | -43,451 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2020 | Feldbaum Carl B47 | Director | Sale+OE | 38,000 | $18.84 | $716,012.68 | -68.2% | |
| Feb 26, 2020 | Morrissey Michael | President And CEO | Sale+OE | 25,000 | $18.91 | $472,850.00 | -12.7% | |
| Feb 19, 2020 | Haley Patrick J.56 | EVP, Commercial | Sale+OE | 5,000 | $22.00 | $110,000.00 | -4.0% | |
| Feb 19, 2020 | Morrissey Michael | President And CEO | Sale+OE | 25,000 | $21.75 | $543,750.00 | -22.5% | |
| Feb 19, 2020 | Schwab Gisela67 | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 40,000 | $21.50 | $860,000.00 | -11.0% | |
| Feb 18, 2020 | Scangos George A77 | Director | Sell | 50,000 | $20.73 | $1,036,500.00 | -4.9% | |
| Feb 14, 2020 | Garber Alan M50 | Director | Sell | 12,500 | $21.02 | $262,750.00 | -20.4% | |
| Feb 13, 2020 | Morrissey Michael | President And CEO | Sale+OE | 25,000 | $20.11 | $502,750.00 | -22.5% | |
| Feb 12, 2020 | Scangos George A77 | Director | Sell | 25,000 | $20.04 | $500,980.00 | -1.2% | |
| Feb 7, 2020 | Schwab Gisela67 | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 50,000 | $18.37 | $918,500.00 | -13.3% |